Sotera Health Company (SHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Apr, 2026Voting matters and shareholder proposals
Four Class III director nominees are up for election to serve until the 2029 Annual Meeting of Stockholders.
Advisory approval of named executive officer compensation is on the agenda.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is proposed.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Annual Meeting will be held virtually on May 21, 2026, at 9:00 a.m. EDT.
Executive compensation and say-on-pay
Advisory vote on executive compensation for named executive officers is included.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sotera Health Company
- CEO transition, regulatory investments, and global expansion drive growth and resilience.SHC
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Leadership transition, steady growth, and robust supply chain investments drive positive outlook.SHC
Jefferies Global Healthcare Conference 20263 Jun 2026 - All proposals passed with strong support amid continued financial growth and strategic focus.SHC
AGM 202621 May 2026 - Strong demand, margin recovery, and new leadership drive positive outlook for the year.SHC
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - Q1 2026 delivered 10% revenue growth, margin expansion, and reaffirmed a strong 2026 outlook.SHC
Q1 20265 May 2026 - Leadership transition appoints Shader as CEO and Petras as Executive Chairman, ensuring continuity.SHC
Proxy filing5 May 2026 - 2025 delivered record revenue and margin growth; 2026 guidance projects further gains.SHC
Q4 202513 Apr 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and governance updates.SHC
Proxy filing8 Apr 2026 - 2026 guidance targets 5%-6.5% growth, with strong momentum and disciplined capital allocation.SHC
2026 KeyBanc Capital Markets Healthcare Forum20 Mar 2026